Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) shares increased 2.79 percent to close at $44.87 a share Friday. The stock traded between $40.50 and $45.98 on volume of 2.41 million shares traded. Analysts at Jefferies maintain a "buy" rating on the company with a price target of $80.00. Shares of Aegerion Pharmaceuticals have fallen approximately 36.0 percent year-to-date.
Find out more about Aegerion Pharmaceuticals including full access to the free equity report at:
www.RDInvesting.com/AEGR
Agios Pharmaceuticals Inc. (NASDAQ: AGIO) shares increased 1.26 percent to close at $37.02 a share Friday. The stock traded between $36.30 and $38.52 on volume of 281,828 shares traded. Analysts at JP Morgan maintain a "neutral" rating on the company with a price target of $40.00. Shares of Agios Pharmaceuticals have gained approximately 55.0 percent year-to-date.
Find out more about Agios Pharmaceuticals including full access to the free equity report at:
www.RDInvesting.com/AGIO
Colfax Corp. (NYSE: CFX) shares declined 0.64 percent to close at $68.56 a share Friday. The stock traded between $68.42 and $69.44 on volume of 711,507 shares traded. Analysts at Longbow Research have recently initiated coverage on the company with a "neutral" rating. Shares of Colfax have fallen approximately 8.0 percent year-to-date.
Find out more about Colfax including full access to the free equity report at:
www.RDInvesting.com/CFX
Integrated Silicon Solution, Inc. (NASDAQ: ISSI) shares increased 4.14 percent to close at $14.58 a share Friday. The stock traded between $14.18 and $14.74 on volume of 321,932 shares traded. Analysts at B. Riley & Co. have recently initiated coverage on the company with a "buy" rating and a price target of $18.00. Shares of Integrated Silicon Solution have gained approximately 20.0 percent year-to-date.
Find out more about Integrated Silicon Solution including full access to the free equity report at:
www.RDInvesting.com/ISSI
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Research Driven Investing
[email protected]